Epidemiology and Clinical Infectious Diseases
Research in epidemiology and clinical infectious diseases is conducted at UVA’s hospital and medical center and at ID partner sites overseas, in areas that include antibiotic resistance (its spread and control), diagnostics, epidemiology of infectious diseases within both patient and general populations, and factors that influence disease susceptibility.
The following division faculty conduct research and instruct fellows in Clinical Infectious Diseases:
Mobile technologies to improve adherence to HIV medications in rural populations.
Recognition, diagnosis, pathogenesis, impact, treatment and prevention of enteric infections; global health and tropical infectious diseases
Antiviral agents for the prevention and treatment of respiratory viral infections
Multidrug resistant tuberculosis (MDR-TB); pharmacokinetics; clinical application of diagnostics for TB; clinical trials to optimize TB treatment; chronic illness/ TB integration
Molecular diagnostics, Tuberculosis, Global Health
Biodefense and emerging pathogens
Molecular epidemiology of multidrug resistant gram negative bacilli, laboratory detection of gram negative antibiotic resistance, prevention of acquisition of resistant bacterial pathogens and treatment of multi-drug resistant gram negative bacteria.
Nutrition and major global infectious diseases; HIV/AIDS; tuberculosis and other respiratory infections; Cryptosporidium and enteric infections
Sepsis pathophysiology with particular interest in the role of the innate immune system; sepsis pathophysiology, management, and outcomes of HIV infected patients in sub-Saharan Africa.
Immune mechanisms of defense against COVID-19 and enteric (diarrheal) infections
Molecular mechanisms of bacterial pathogenesis, sepsis/septic shock, adenosine receptors, inflammation, innate immunity, anthrax, vaccines
Hospital epidemiology, immunocompromised infectious diseases, molecular pathogenesis and epidemiology, innate immunity
Pediatric tuberculosis: epidemiology and biomarkers for diagnosis/prognosis
Prevention and treatment of C. difficile infection. Role of microbiota in health and disease. Infections in special populations- elderly, pregnant women and racial/ethnic minority groups.